PMID: 7968065Nov 12, 1994Paper

Lamotrigine in infantile spasms

P VeggiottiO Dulac


No abstract listed.


Jan 1, 1992·European Neurology·P L Timmings, A Richens
Jan 1, 1991·Journal of Child Neurology·C ChironJ Mumford

❮ Previous
Next ❯


Dec 7, 2000·Mental Retardation and Developmental Disabilities Research Reviews·J M Pellock, L D Morton
May 21, 1998·Pharmacology & Therapeutics·J A Hannah, M J Brodie
Nov 10, 2001·Brain & Development·Y Suzuki
Oct 18, 2000·Pediatric Neurology·T KishiK Ueda
Mar 29, 2001·Pediatric Neurology·M Wong, E Trevathan
Sep 28, 2002·Epilepsy Research·Carlo CianchettiAntonio Pascotto
Sep 11, 1998·Seizure : the Journal of the British Epilepsy Association·H SiemesB Weschke
May 1, 2002·Clinical Neuropharmacology·Mohamad A MikatiGregory L Holmes
May 14, 1998·Epilepsia·Y SuzukiS Okada
Dec 22, 1998·Epilepsia·T A GlauserR Strawsburg
Sep 16, 1998·Epilepsia·M Ito
Oct 26, 1999·Epilepsia·F Matsuo
Oct 26, 1999·Epilepsia·J M Pellock, R Appleton
Dec 28, 1999·Epilepsia·J M PinardO Dulac
Aug 11, 2000·Pharmacotherapy·J M Pellock
Jun 27, 2009·Neuropsychiatric Disease and Treatment·Chang-Yong Tsao
Apr 2, 2003·Expert Opinion on Pharmacotherapy·Ann M Bergin
Jan 7, 2011·Expert Opinion on Pharmacotherapy·Alberto VerrottiFrancesco Chiarelli
Sep 25, 2008·Arquivos de neuro-psiquiatria·Karen P GrisottoLúcia H C Santos
Mar 6, 2003·Neurologic Clinics·Ann M Bergin, Mary Connolly
Mar 13, 2003·Mayo Clinic Proceedings·Randa G Jarrar, Jeffrey R Buchhalter
Feb 24, 2001·Journal of Child Neurology·T A Glauser
Jun 29, 2002·Journal of Child Neurology·Michael DuchownyUNKNOWN LAMICTAL Pediatric Study Group
Jul 29, 2008·Journal of Child Neurology·Jesús Eric Piña-GarzaJohn A Messenheimer
Apr 16, 2002·Journal of Child Neurology·John Messenheimer
Apr 16, 2002·Journal of Child Neurology·Edwin Trevathan
Jul 15, 2000·Clinical Neuropharmacology·B F Bourgeois
Aug 31, 2006·Yonsei Medical Journal·Young-Se KwonByong-Kwan Son
Oct 23, 2001·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·R Nabbout
Jun 21, 2006·Expert Review of Neurotherapeutics·Alberto VerrottiEmilio Franzoni
Dec 6, 2006·Expert Review of Neurotherapeutics·Sheetal MalikLawrence J Hirsch
Mar 19, 2020·Pharmacogenetics and Genomics·Taraswi Mitra-GhoshRuss B Altman
Sep 13, 2016·Epilepsia·Kelly G KnuppUNKNOWN Pediatric Epilepsy Research Consortium
Aug 20, 2016·Paediatric Drugs·Anand Iyer, Richard Appleton
Apr 23, 2020·Expert Review of Neurotherapeutics·Nicola SpecchioPaolo Curatolo
Aug 18, 2000·Paediatric Drugs·C R Culy, K L Goa
Jun 7, 2013·The Cochrane Database of Systematic Reviews·Eleanor C HancockStuart W Edwards
Aug 12, 2006·Journal of Child Neurology·Jerry R McKeeAnn E Hammer

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.